nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos display a reduction in abdominal segmentation, forming an average of 6 of the 8 abdominal segments characteristic of wild-type embryos.
Heterozygous embryos do not show segmentation defects.
Approximately 19% of pole cells in embryos derived from nosBN females are undergoing apoptosis at stage 12-14. Around 33% of pole cells are undergoing apoptosis at stage 14-16.
Beginning at stage 9/10, most pole cells are lost in embryos derived from homozygous females. The pole cells in these embryos sometimes show irregular shapes characteristic of apoptotic cells and 19.7% are TUNEL-positive.
Homozygotes show severe head involution defects in only 4% of larvae.
The average number of pole cells per embryo is reduced compared to controls in embryos derived from homozygous females.
Germ cells clump prematurely and stay in the middle of the embryo.
The effects of loss of maternal and zygotic nos product on germ cell migration is studied in females with hb15 nosBN mutant germ line clones crossed to nos18/Df(3R)Dl-FX3 males. Germ cells are formed in the embryos indicating nos function is not required for their formation. nos activity is essential for germ cell migration, from stage 10 onwards. Following exit of the germ cells of the posterior midgut pocket, germ cells fail to migrate over the surface of the gut and instead cluster tightly together on the outer gut surface. Mutant germ cells are of varying size and often have an irregular surface. Zygotic nos expression cannot compensate for the loss of maternal nos. The few germ cells that appear to associate with the somatic embryonic gonad are unable to incorporate into the adult gonad even in the presence of a zygotically active copy of the gene.
Pole cells fail to migrate into the gonads. Transplantation of pole cells into hosts that can form normal abdomens demonstrates the pole cells cannot penetrate the gonads. No ovoD1 females transplanted with nosBN pole cells produce progeny, also demonstrating the pole cells cannot penetrate the gonads.
nanosBN has increased cell death | embryonic stage 14 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 15 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 16 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 13 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has increased cell death | embryonic stage 14 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has increased cell death | embryonic stage 15 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has increased cell death | embryonic stage 16 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has increased cell death | embryonic stage 13 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 14 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 15 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has increased cell death | embryonic stage 16 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has increased cell death | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has increased cell death | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has increased cell death | maternal effect | embryonic stage 15 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has increased cell death | maternal effect | embryonic stage 16 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has increased cell death | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has increased cell death | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has increased cell death | maternal effect | embryonic stage 15 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has increased cell death | maternal effect | embryonic stage 16 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has increased cell death | maternal effect | embryonic stage 12 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has increased cell death | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has increased cell death | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has increased cell death | maternal effect | embryonic stage 13 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has increased cell death | maternal effect | embryonic stage 14 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has increased cell death | maternal effect | embryonic stage 15 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has increased cell death | maternal effect | embryonic stage 16 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN is an enhancer of partially lethal - majority die | embryonic stage | maternal effect | germline clone phenotype of hb15
nanosBN/nanosL7 is a suppressor | partially of abnormal size | oogenesis phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of increased cell number | oogenesis phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a non-suppressor | partially of abnormal size | oogenesis phenotype of l(3)mbtGM76/Df(3R)ED10966
mof1, nanosBN has decreased fecundity | female phenotype
nanosBN, nsl106536 has decreased fecundity | female | progressive phenotype
nanosBN, nsl1c04892 has decreased fecundity | female | progressive phenotype
nanosBN, nsl1+t9.9, nsl11 has decreased fecundity | female | progressive phenotype
nanosBN, nsl11 has female semi-sterile phenotype
nanosBN, nsl11 has decreased fecundity | female | progressive phenotype
nanos+1+3.Tag:MS2, nanosBN has abdominal segment phenotype, enhanceable by Df(2L)BSC32/+
nanos+1+3.Tag:MS2, nanosBN has abdominal segment phenotype, enhanceable by aub[+]/aubQC42
nanos+1+3.Tag:MS2, nanosBN has abdominal segment phenotype, enhanceable by aub[+]/aubHN2
nanosΔBX, nanosBN has embryonic abdominal segment phenotype, enhanceable by nsl11/wah[+]
nanosΔBX, nanosBN has embryonic abdominal segment phenotype, enhanceable by nsl106536/wah[+]
nanosΔBX, nanosBN has embryonic abdominal segment phenotype, enhanceable by wah[+]/nsl1c04892
nanosΔBX, nanosBN has embryonic abdominal segment phenotype, enhanceable by Df(3R)Exel8162/+
nanosBN has primordial germ cell | embryonic stage 14 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 15 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 16 | maternal effect phenotype, enhanceable by hidUASp.Tag:FLAG/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 13 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has primordial germ cell | embryonic stage 14 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has primordial germ cell | embryonic stage 15 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has primordial germ cell | embryonic stage 16 | maternal effect phenotype, enhanceable by Scer\GAL4VP16.nanos.UTR/TaoUASp.Tag:FLAG
nanosBN has primordial germ cell | embryonic stage 13 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 14 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 15 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosBN has primordial germ cell | embryonic stage 16 | maternal effect phenotype, enhanceable by sklUASp.cSa/Scer\GAL4VP16.nanos.UTR
nanosΔBX, nanosBN has embryonic abdominal segment | maternal effect phenotype, enhanceable | maternal effect by Hsp83A133D/Hsp83[+]
nanosΔBX, nanosBN has embryonic abdominal segment | maternal effect phenotype, enhanceable | maternal effect by Hsp83e6D/Hsp83[+]
nanosΔBX, nanosBN has embryonic abdominal segment | maternal effect phenotype, enhanceable | maternal effect by Hsp83[+]/Hsp83e6A
nanos+1+3.Tag:MS2, nanosBN has abdominal segment phenotype, non-enhanceable by squ[+]/squHE47
nanosΔBX, nanosBN has embryonic abdominal segment | maternal effect phenotype, non-enhanceable by Hsp83j5C2/Hsp83[+]
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has primordial germ cell | maternal effect | embryonic stage 16 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has primordial germ cell | maternal effect | embryonic stage 12 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has primordial germ cell | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has primordial germ cell | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has primordial germ cell | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has primordial germ cell | maternal effect | embryonic stage 13 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has primordial germ cell | maternal effect | embryonic stage 14 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has primordial germ cell | maternal effect | embryonic stage 15 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
nanosBN has primordial germ cell | maternal effect | embryonic stage 16 phenotype, suppressible by Scer\GAL4VP16.nanos.UTR/TaoD168A.UASp.Tag:FLAG
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has primordial germ cell | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has primordial germ cell | maternal effect | embryonic stage 15 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, TaoUASp.Tag:FLAG, nanosBN has primordial germ cell | maternal effect | embryonic stage 16 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has primordial germ cell | maternal effect | embryonic stage 13 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has primordial germ cell | maternal effect | embryonic stage 14 phenotype, suppressible by hid05014/Df(3L)H99
Scer\GAL4VP16.nanos.UTR, nanosBN, sklUASp.cSa has primordial germ cell | maternal effect | embryonic stage 15 phenotype, suppressible by hid05014/Df(3L)H99
nanosBN has phenotype, suppressible by Dvir\nanostCa
nanosΔBX, nanosBN has embryonic abdominal segment | maternal effect phenotype, non-suppressible by Hsp83j5C2/Hsp83[+]
nanosBN has abdominal segment phenotype, non-suppressible by Hmag\nanos1nos.UTR
nanosBN/nanos+1+3.Tag:MS2 is an enhancer of abdominal segment phenotype of rump1
nanosBN/nanos+1+3.Tag:MS2 is an enhancer of abdominal segment phenotype of aub[+]/aubQC42, rump1
nanosBN/nos[+] is an enhancer of embryonic abdominal segment phenotype of rump1
nanosBN/nanosL7 is a suppressor | partially of egg chamber phenotype of lkyKO
nanosBN/nanosL7 is a suppressor | partially of ovary phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of ovariole phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of egg chamber phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of female germline cell | increased number phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of nurse cell | increased number phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of oocyte | increased number phenotype of l(3)mbtGM76/Df(3R)ED10966
nanosBN/nanosL7 is a suppressor | partially of follicle cell phenotype of l(3)mbtGM76/Df(3R)ED10966
nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos carrying a Df(2L)BSC32/+ mutation display a reduction in abdominal segmentation, forming an average of 2.4 abdominal segments.
nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos carrying a aubQC42/+ mutation display a reduction in abdominal segmentation, forming an average of 2-3 abdominal segments. Mutant embryos display the normal number of pole cells.
nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos carrying a aubHN/+ mutation display a reduction in abdominal segmentation, forming an average of 3-4 abdominal segments.
nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos carrying a squHE47/+ mutation do not display a reduction in abdominal segmentation compared to nosBN,nos+1+3.T:MS2\MCP.BS/nosBN embryos.
rump1 mutant embryos carrying a nosBN, nos+1+3.T:MS2\MCP.BS/nosBN mutation display an increase in the number of embryos that develop less than 8 abdominal segments.
rump1 mutant embryos carrying an aubQC42/+ mutation, and the mutation nosBN, nos+1+3.T:MS2\MCP.BS/nosBN , display an increase in the number of embryos that develop less than 8 abdominal segments.
nosΔBX, nosBN/nosBN females that are also heterozygous for wah1 give rise to embryos that rarely hatch, concomitant with a reduction in the average number of abdominal segments from 3.7 to 1.9.
nosΔBX, nosBN/nosBN females that are also heterozygous for wah06536, wahc04892 or Df(3R)Exel8162 give rise to embryos with a reduction in the average number of abdominal segments.
wah1 nosBN/nosBN females appear to be significantly less fertile than nosBN/nosBN females.
In contrast to nosBN homozygous ovaries, ovaries from wah1 nosBN/nosBN females have few normal ovarioles: many contain either no maturing egg chambers or only a single mature stage 13/14 oocyte; and many contain aberrant, small egg chambers that contain only one or two highly polyploid germ line nuclei.
In contrast to nosBN/nosBN females, wah1, nosBN/nosBN females produce eggs for only 5-6 days after eclosion.
wah06536, nosBN/nosBN females exhibit more than tenfold lower fecundity between days 9 and 13 than between days 3 and 8.
wahc04892, nosBN/nosBN females exhibit more than tenfold lower fecundity between days 9 and 13 than between days 3 and 8.
wah1, nosBN/nosL7 females do not exhibit age-dependent loss of fecundity.
A single copy of wah+t9.9 can rescue the age-dependent female infertility of wah1, nosBN/nosBN females. However, wah1, nosBN homozygotes expressing a single copy of wah+t9.9 exhibit age-dependent infertility, producing no eggs after the 8th day post-eclosion.
In ovarioles from very young wah1, nosBN/nosBN flies, the spectrosomes of germline stem cells and cystoblasts and the fusomes of immature cysts appear normal. But slightly older ovaries are bereft of germline cells: some germaria contain only one or two germline cysts and many have none. In these older ovaries, differentiation or development of the few remaining cysts is abnormal, many of which contain one or two large polyploid cells.
Doubly homozygous mof1; nosBN females are nearly as prolific as nosBN controls 3-8 days post-eclosion. However, their fecundity drops dramatically 9-13 days post-eclosion.
The frequency and severity of abdominal segmentation defects in embryos derived from rump1 homozygous females is increased by one copy of nosBN. Abdominal segments 4 and 5 are most frequently affected.
The ability of nosnos.+2.Hsp83 to rescue abdominal segmentation of nosBN embryos is severely compromised in a rump1/Df(3R)by416 background; more than 90% of the embryos develop fewer than 4 abdominal segments.
Removal of zygotic W (W05014/Df(3L)H99) suppresses the pole cell apoptosis seen in embryos derived from nosBN females. Approximately 7% of pole cells examined at stage 12-14 are undergoing apoptosis.
Expression of WScer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 enhances the pole cell apoptosis seen in stage 14-16 embryos derived from nosBN females.
Expression of Tao-1D168A.Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 suppresses the pole cell apoptosis seen in stage 13-16 embryos derived from nosBN females.
Expression of Tao-1Scer\UAS.P\T.T:Zzzz\FLAG under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 enhances the pole cell apoptosis seen in stage 13-16 embryos derived from nosBN females.
Expression of sklScer\UAS.P\T.cSa under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 enhances the pole cell apoptosis seen in stage 13-16 embryos derived from nosBN females.
Removal of zygotic W (W05014/Df(3L)H99) suppresses the pole cell apoptosis seen when Tao-1Scer\UAS.P\T.T:Zzzz\FLAG is expressed under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 in stage 13-16 embryos derived from nosBN females.
Removal of zygotic W (W05014/Df(3L)H99) suppresses the pole cell apoptosis seen when sklScer\UAS.P\T.cSa is expressed under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 in stage 13-16 embryos derived from nosBN females.
Homozygous Df(3L)H99 embryos that are derived from nosBN homozygous females show a suppression of the apoptosis of the pole cells that is seen in embryos derived from nosBN homozygous females mated to wild-type males. These rescued "pole cells" (from homozygous Df(3L)H99 embryos that are derived from nosBN homozygous females) can become integrated into somatic tissues, such as midgut epithelium, tracheal epithelium and gastric caeca, when transplanted into host embryos (this is not seen with either control pole cells or pole cells derived from nosBN homozygous females mated to wild-type males). The pole cells that are integrated into somatic tissues are morphologically indistinguishable from their neighbouring host cells. In addition, the rescued "pole cells" are incorporated into gonads in approximately 25% of cases, when transplanted into host embryos (this phenotype is not seen when pole cells derived from nosBN homozygous females mated to wild-type males are transplanted into host embryos). These pole cells are morphologically indistinguishable from the host pole cells, but do not contribute to egg or sperm production.
No genetic interaction in terms of abdominal segmentation is seen in the cupunspecified/+ ; nosBN combination. No genetic interaction in terms of abdominal segmentation is seen in the cupunspecified/nosΔBX ; nosBN combination.
When embryos are also mutant for SxlfP7B0, the germ cells form two clusters instead of one.
Hmag\nos1nos.UTR fails to rescue the abdominal defects of embryos derived from nosBN females.
Two copies of P{Dvnos} partially rescues the mutant phenotype.
nanosBN is rescued by nanosnanos.+1.+2'
nanosBN is rescued by nanosnanos.+2'A-3X.Tag:HA
nanosBN is rescued by nanosnanos.+2'B-3X.Tag:HA
nanosBN is rescued by nanosnanos.+2'D-3X.Tag:HA
nanosBN is rescued by nanosnanos.+2'C-3X.Tag:HA
nanosBN is rescued by nanosnanos.+2'ME-3X.Tag:HA
nanosBN is rescued by nanosnanos.+2.Hsp83
nanosBN is rescued by nanosTCE.IIIGC
nanosBN is rescued by nanosTCE.IIIA.Tloop
nanosBN is rescued by nanosTCE.IIIA:U
nanosBN is rescued by nanosTCE.IIIU
nanosBN is rescued by nanosTCE.IIIGC:GC
nanosBN is rescued by nanosTCEIIU
nanosBN is rescued by nanosTCEIIA
nanosBN is rescued by nanosTCE.IIIA
nanosBN is rescued by nanos+t5.7
nanosBN is rescued by nanosnanos.+2.Hsp83
nanosBN is rescued by nanosnanos.+2'-3X.Tag:HA
nanosBN is rescued by nanos+4.4.Tag:HA
nanosBN is partially rescued by nanosTCEIIUC.AG
nanosBN is partially rescued by nanosnanos.+2.Hsp83
nanosBN is partially rescued by nanosnanos.+2'F-3X.Tag:HA
nanosBN is partially rescued by nanosnanos.+2'E-3X.Tag:HA
nanosBN is partially rescued by nanosnanos.+2RO.Tag:HA
nanosBN is partially rescued by nanosnanos.+2E.Tag:HA
nanosBN is partially rescued by nanosnanos.+2C.Tag:HA
nanosBN is partially rescued by nanosTCE.IIIA:U^C72
nanosBN is partially rescued by nanosTCE.IIIA:U.Tloop
nanosBN is partially rescued by nanosαTub84B.UTR.Tag:HA
nanosBN is partially rescued by nanosnanos.+1.Hsp83
nanosBN is partially rescued by nanosTCEIII.TLoop
nanosBN is partially rescued by nanosnanos.+2.U51A
nanosBN is partially rescued by nanosnanos.+2.IIA:U
nanosBN is partially rescued by nanosTCEIII.U51A
nanosBN is partially rescued by nanosnanos.+2'.Hsp83
nanosBN is partially rescued by nanosnanos.+4.Hsp83
nanosBN is partially rescued by nanosnanos.+4-3X.Tag:HA
nanosBN is partially rescued by nanosnanos.+3-2X.Tag:HA
nanosBN is partially rescued by nanosnanos.+2-3X.Tag:HA
nanosBN is partially rescued by nanosnanos.+4-2X.Tag:HA
nanosBN is partially rescued by nanosnanos.+3.Hsp83
nanosBN is partially rescued by nanosnanos.+2-2X.Tag:HA
nanosBN is partially rescued by nanosnanos.+3-3X.Tag:HA
nanosBN is partially rescued by nanosnanos.+2'-2X.Tag:HA
nanosBN is not rescued by nanosnanos.+2A.Tag:HA
nanosBN is not rescued by nanosTCE.ΔProxIII
nanosBN is not rescued by nanosnanos.IIA:U+U51A
nanosBN is not rescued by nanosαTub84B.UTR.virTCE.Tag:HA
nanosBN is not rescued by nanosTCEIIA.U
nanosBN is not rescued by nanosTCE.II^III.Tag:HA
nanosBN is not rescued by nanosnanos.+2.IIA:U+U51A
Cytoplasm from the posterior pole of D.pseudoobscura.pseudoobscura, D.virilis, D.hydei, M.domestica and C.samoensis embryos is injected into the abdominal region of homozygous early cleavage stage embryos. Injected embryos displayed partial or complete abdominal segmentation, the frequency of strong rescue decreases with increasing evolutionary distance of the donor.